NASDAQ: BNOX - Bionomics Limited

六个月盈利: -49.58%
部门: Healthcare

促销时间表 Bionomics Limited

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder.

更多详情
It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. The company has a collaboration with Merck & Co., Inc. to identify novel a7 Nicotinic Acetylcholine Receptor PAMs suitable for the treatment of cognitive disorder. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2021-12-16
ISIN US09063M2052
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета aud
Сайт https://www.bionomics.com.au
Цена ао 0.278
每日价格变化: -9.44% (4.45)
每周价格变化: +38.26% (2.9148)
每月价格变化: +12.7% (3.576)
3个月内价格变化: -47.51% (7.6776)
六个月内的价格变化: -49.58% (7.9932)
每年价格变化: +172.3% (1.48)
3年内价格变化: -68.64% (12.85)
5年内价格变化: 0% (4.03)
10年价格变化: 0% (4.03)
年初以来价格变化: +20.33% (3.3492)
所有参数

低估

姓名 意义 年级
P/S 4290.29 1
P/BV 4.91 3
P/E 0 0
EV/EBITDA -7.47 0
全部的: 2.75

效率

姓名 意义 年级
ROA, % -66284.99 0
ROE, % -117366.73 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.027 10
全部的: 9.6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -99.32 0
盈利能力 Ebitda, % -88.49 0
盈利能力 EPS, % 2304445.45 10
全部的: 4
更多详情

机构 体积 分享, %
Lynx1 Capital Management Lp 824305 10.1
Point72 Asset Management, L.P. 331000 4.06
Morgan Stanley 94967 1.16
Two Sigma Investments, LP 31272 0.38
XTX Topco Ltd 11834 0.15
Tower Research Capital LLC (TRC) 1606 0.02
Rhumbline Advisers 505 0.01
UBS Group AG 329 0
Aspire Private Capital, LLC 200 0



导师 职称 支付 出生年份
Dr. Spyridon Papapetropoulos M.D., Ph.D. CEO, President & Director 510.37k 1973 (52 年)
Mr. Timothy M. Cunningham CPA, M.B.A. Chief Financial Officer N/A 1963 (62 年)
Dr. Julie Kerner Ph.D. Senior Vice President of Business Operations N/A
Ms. Elizabeth Doolin Senior Vice President of Clinical Development 1965 (60 年)
Dr. Mark A. Smith M.D., Ph.D. Chief Medical Officer 1955 (70 年)

地址: Australia, Eastwood, 200 Greenhill Road - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.bionomics.com.au